Upgrade to SI Premium - Free Trial

Amgen (AMGN) PT Raised to $205 at Bernstein Following 4Q

February 2, 2018 8:06 AM
Bernstein raised its price target on Amgen (NASDAQ: AMGN) to $205.00 (from $189.00) while maintaining a Market Perform ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles